Norris Medicines has informed that it enclosed a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the period 1st April, 2021 to 30th June, 2021, received from Purva Sharegistry (I), Registrar and Share Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE.